Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,658B 53.32B 46.6B 43B 39.64B 74.71B 5,135B 76.36B 514B 202B 2,515B 200B 196B P/E 2027 *
44.1x
P/E 2028 * 28.4x
Enterprise Value 12,544B 77.26B 67.52B 62.3B 57.43B 108B 7,440B 111B 745B 293B 3,644B 290B 284B EV / Sales 2027 *
2.71x
EV / Sales 2028 * 2.64x
Free-Float
99.26%
Yield 2027 *
3.73%
Yield 2028 * 3.81%
1 day+2.53%
1 week+2.26%
Current month+6.30%
1 month+8.79%
3 months-1.90%
6 months+8.02%
Current year+13.34%
1 week 5,249
Extreme 5249
5,496
1 month 4,897
Extreme 4897
5,527
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 23/06/2026
Director of Finance/CFO 48 31/03/2024
Chief Tech/Sci/R&D Officer 47 31/01/2022
Director TitleAgeSince
Director/Board Member 60 31/05/2015
Director/Board Member 73 31/12/2018
Director/Board Member 48 31/05/2024
Date Insider Type Main position Quantity % Market Cap.
10/07/26 Issuer sale

Director

-1,152 0.0001%
10/07/26 Issuer sale

Chairman

-2,152 0.0001%
10/07/26 Issuer sale

Chief Financial Officer; Director

-16,619 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+2.53%+2.26%+26.24%+27.74% 53.32B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average +0.19%+0.71%+28.31%+51.29% 362.84B
Weighted average by Cap. +0.40%+0.06%+37.34%+78.87%

Financials

2027 *2028 *
Net sales 4,637B 28.56B 24.96B 23.03B 21.23B 40.01B 2,750B 40.9B 275B 108B 1,347B 107B 105B 4,707B 28.99B 25.33B 23.38B 21.55B 40.62B 2,792B 41.52B 279B 110B 1,367B 109B 106B
Net income 186B 1.14B 1B 923M 851M 1.6B 110B 1.64B 11.04B 4.34B 54B 4.3B 4.21B 311B 1.92B 1.67B 1.55B 1.42B 2.68B 185B 2.74B 18.47B 7.27B 90.38B 7.2B 7.04B
Net Debt 3,887B 23.94B 20.92B 19.3B 17.79B 33.54B 2,305B 34.28B 231B 90.75B 1,129B 89.9B 87.92B 3,751B 23.1B 20.19B 18.63B 17.17B 32.37B 2,225B 33.08B 223B 87.58B 1,090B 86.76B 84.86B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
17/07/26 JP¥5,480.00 +2.53% 5,074,900
16/07/26 JP¥5,345.00 +1.08% 5,369,900
15/07/26 JP¥5,288.00 -0.73% 2,986,600
14/07/26 JP¥5,327.00 +0.17% 3,586,400
13/07/26 JP¥5,318.00 -0.77% 2,451,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,480.00JPY
Average target price
6,126.87JPY
Spread / Average Target
+11.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock